# FDA Inspection 1015061 - Bahman Guyuron - June 21, 2017

Source: https://www.keypedia.com/records/fda_inspections/bahman-guyuron/7f356742-5071-4e5d-a90b-d2d3d27bd022
Source feed: FDA_Inspections

> FDA Inspection 1015061 for Bahman Guyuron on June 21, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1015061
- Company Name: Bahman Guyuron
- Inspection Date: 2017-06-21
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/bahman-guyuron/b7df6c60-32f5-4ccb-b2cf-dcb56551f4ae

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c